key: cord-0718062-kj58edml authors: Calisher, Charles H; Carroll, Dennis; Colwell, Rita; Corley, Ronald B; Daszak, Peter; Drosten, Christian; Enjuanes, Luis; Farrar, Jeremy; Field, Hume; Golding, Josie; Gorbalenya, Alexander E; Haagmans, Bart; Hughes, James M; Keusch, Gerald T; Lam, Sai Kit; Lubroth, Juan; Mackenzie, John S; Madoff, Larry; Mazet, Jonna Keener; Perlman, Stanley M; Poon, Leo; Saif, Linda; Subbarao, Kanta; Turner, Michael title: Science, not speculation, is essential to determine how SARS-CoV-2 reached humans date: 2021-07-05 journal: Lancet DOI: 10.1016/s0140-6736(21)01419-7 sha: 9cf4866e1533d3f5d528110bddde507879bfd929 doc_id: 718062 cord_uid: kj58edml nan On Feb 19, 2020, we, a group of physicians, veterinarians, epi demi ologists, virologists, biologists, ecologists, and public health experts from around the world, joined together to express solidarity with our professional colleagues in China. 1 Unsubstantiated allegations were being raised about the source of the COVID19 outbreak and the integrity of our peers who were diligently working to learn more about the newly recognised virus, SARSCoV2, while struggling to care for the many patients admitted to hospital with severe illness in Wuhan and elsewhere in China. It was the beginning of a global tragedy, the COVID19 pandemic. According to WHO, as of July 2, 2021, the pandemic has resulted in 182 101 209 confirmed cases and 3 950 876 deaths, both undoubtedly underestimates of the real toll. The impact of the pandemic virtually everywhere in the world has been far worse than even these numbers suggest, with unprecedented addi tional social, cultural, political, and economic consequences that have exposed numerous flaws in our epi demic and pandemic preparedness and in local and global political and economic systems. We have observed escalations of conflicts that pit many parties against one another, including central government versus local government, young versus old, rich versus poor, people of colour versus white people, and health priorities versus the economy. The crisis has highlighted the urgent need to build a better understanding of how science pro ceeds and the complex, but critical, links science has with health, public health, and politics. Recently, many of us have indi vidually received inquiries asking whether we still support what we said in early 2020. 1 The answer is clear: we reaffirm our expression of solidarity with those in China who confronted the outbreak then, and the many health professionals around the world who have since worked to exhaustion, and at personal risk, in the relentless and continuing battle against this virus. Our respect and gratitude have only grown with time. The second intent of our original Correspondence was to express our working view that SARSCoV2 most likely originated in nature and not in a laboratory, on the basis of early genetic analysis of the new virus and well established evidence from previous emerging infectious diseases, including the coronaviruses that cause the common cold as well as the original SARSCoV and MERSCoV. 2 Opinions, however, are neither data nor conclusions. Evidence obtained using the scientific method must inform our understanding and be the basis for interpretation of the available information. The process is not error free, but it is selfcorrecting as good scientists endeavour to continually ask new questions, apply new meth odologies as they are developed, and revise their conclusions through an open and transparent sharing of data and ongoing dialogue. The critical question we must address now is, how did SARSCoV2 reach the human population? This is important because it is such insights that will drive what the world must urgently do to prevent another tragedy like COVID19. We believe the strongest clue from new, credible, and peer reviewed evidence in the scientific literature 3-6 is that the virus evolved in nature, while suggestions of a laboratoryleak source of the pandemic remain without scientifically validated evidence that directly supports it in peerreviewed scientific journals. 7, 8 Careful and transparent collection of scientific information is essential to understand how the virus has spread and to develop strategies to mitigate the ongoing impact of COVID19, whether it occurred wholly within nature or might somehow have reached the community via an alternative route, and prevent future pandemics. Allegations and conjecture are of no help, as they do not facilitate access to information and objective assessment of the pathway from a bat virus to a human pathogen that might help to prevent a future pandemic. Recrimination has not, and will not, encourage international cooperation and collaboration. 9 New viruses can emerge anywhere, so main taining transparency and cooperation between scientists everywhere pro vides an essential early warning system. Cutting professional links and reducing data sharing will not make us safer. We welcome calls for scien tifically rigorous investigations. 10, 11 To accomplish this, we encourage WHO and scientific partners across the world to expeditiously move to continue and further extend their initial investigation with experts in China and the Chinese Government. WHO's report from March, 2021, 12 must be considered the beginning rather than the end of an inquiry, and we strongly support the G7 leaders' call for "a timely, transparent, expert led, and sciencebased WHOconvened phase 2 COVID19 origins study". 13 We also understand that it might take years of field and laboratory study to assemble and link the data essential to reach rational and objective conclusions, but that is what the global scientific community must strive to do. It is time to turn down the heat of the rhetoric and turn up the light of scientific inquiry if we are to be better prepared to stem the next pandemic, whenever it comes and wherever it begins. Meanwhile, people around the world continue to be infected by SARSCoV2, many are suffering severe disease and longterm sequelae, and too many are dying. Too many populations lack access to SARSCoV2 testing, COVID19 treatments, and safe and effective vaccines, which will inevitably perpetuate the pandemic and its consequences. At the very least, we owe it to all who have suffered from COVID19, as well as our families and the global community, to work collaboratively to end the pandemic and support international efforts to ensure vaccine equity, even as we prepare for the next pandemic. 14 Having robust surveillance and detection systems in place across the globe is essential to detect and report new or evolving pathogens that can potentially unleash the next local or global threat, as required by the International Health Regulations. Equally essential will be ensuring that the field workforce, laboratory facilities, and the healthcare community can all work under the safest conditions. Until this pandemic ends, we ask, as we did in February, 2020, 1 for solidarity and rigorous scientific data. PD's remuneration is paid solely in the form of a salary from EcoHealth Alliance, a 501(c)(3) nonprofit organisation. EcoHealth Alliance's mission is to develop sciencebased solutions to prevent pandemics and promote conservation. Funding for this work comes from a range of US Government funding agencies and nongovernmental sources. All past and current funders are listed publicly, and full financial accounts are filed annually and published. EcoHealth Alliance's work in China was previously funded by the US National Institutes of Health (NIH) and the United States Agency for International Development (USAID). Neither PD nor EcoHealth Alliance have received funding from the People's Republic of China. PD joined the WHO-China joint global study on the animal origins of SARSCoV2 towards the end of 2020 and is currently a member. As per WHO rules, this work is undertaken as an independent expert in a private capacity, not as an EcoHealth Alliance staff member. The work conducted by this study was published in March, 2021. EcoHealth Alliance's work in China includes collaboration with a range of universities and governmental health and environmental science organisations, all of which are listed in prior publications, three of which received funding from US federal agencies as part of EcoHealth Alliance grants or cooperative agreements, as publicly reported by NIH. EcoHealth Alliance's work in China is currently unfunded. All federally funded subcontractees are assessed and approved by the respective US federal agencies in advance and all funding sources are acknowledged in scientific publications as appropriate. EcoHealth Alliance's work in China involves assessing the risk of viral spillover across the wildlife-livestock-human interface, and includes behavioural and serological surveys of people, and ecological and virological analyses of animals. This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARSrelated coronaviruses that are now used as reagents to test therapeutics and vaccines. It also includes the Origin and crossspecies transmission of bat coronaviruses in China The COVID lableak hypothesis: what scientists do and don't know The lab leak theory doesn't hold up. The rush to find a conspiracy around the COVID19 pandemic's origins is driven by narrative, not evidence Protect scientific collaboration from geopolitics Investigate the origins of COVID19 Let scientific evidence determine origin of SARSCoV2, urge Presidents of the National Academies WHOconvened global study of origins of SARSCoV2: China part Carbis Bay G7 Summit communiqué. Our shared agenda for global action to build back better Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development